Observational study on gastric precancerous conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Gastric Precancerous Conditions Study (GAPS) aims to observe patients at elevated risk for gastric cancer, focusing on those with precursors like atrophic gastritis and intestinal metaplasia. This observational study will recruit both symptomatic and asymptomatic individuals undergoing endoscopy at Stanford Health Care. Participants will include those with known precursor lesions or those at high risk for developing them, allowing for a comprehensive understanding of the progression towards gastric cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria: Subjects between the ages of 35 and 84, who are undergoing outpatient endoscopy for the following indications are eligible: abdominal pain, dyspepsia, iron deficiency anemia, Helicobacter assessment, surveillance of suspected or known intestinal metaplasia, evaluation for family history of gastric cancer

Exclusion Criteria:

* Cannot give consent
* Have history of gastric surgery
* Have history of solid tumor or bone marrow transplant
* Platelet Count \< 70 or international normalized ratio \> 1.5

Where it's running

• Stanford University
  Stanford, California, United States Recruiting

Study contacts

• Principal investigator: Robert J Huang, MD — Stanford University
• Study coordinator: Robert J Huang, MD
• Email: rjhuang@stanford.edu
• Phone: 650-725-0634

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prevalence and possible role of non-H. pylori Helicobacter species in gastric conditions and cancers

  Researchers will test stomach tissue from people with functional dyspeasia, various gastritis conditions, gastric cancer, and bariatric patients to see if non-H. pylori Helicobacter species are present.

  Recruiting at 3 sites Universiteit Antwerpen · Edegem and 2 other locations · NCT07770126

• Adding Saccharomyces boulardii to bismuth quadruple therapy for H. pylori rescue

  This tests whether adding the probiotic Saccharomyces boulardii to bismuth-containing quadruple therapy helps adults whose H. pylori infection did not clear after prior treatments.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07139366

• AI-guided health recommendations for gastric cancer prevention

  This study is testing an AI tool that helps doctors spot early signs of stomach issues and gives personalized advice to prevent gastric cancer.

  Recruiting Fundación para la Investigación del Hospital Clínico de Valencia · Valencia · NCT06421324

• Assessing H. pylori infection rates and antibiotic resistance in Germany

  This study is trying to find out how common H. pylori infections are in Germany and if the bacteria are resistant to antibiotics, so doctors can better treat patients.

  Recruiting Technical University of Munich · Munich · NCT05561504

• Predicting gastric cancer risk in patients with intestinal metaplasia and atrophic gastritis

  This study is trying to find out which factors can help predict the risk of gastric cancer in patients who have intestinal metaplasia and atrophic gastritis.

  Recruiting Chinese University of Hong Kong · Shatin, New Territories · NCT04840056

• Monitoring patients with precursors to gastric cancer

  This study is testing the best ways to monitor people over 45 with early signs of stomach cancer to help keep them safe and healthy.

  Recruiting Instituto Portugues de Oncologia, Francisco Gentil, Porto · Porto · NCT04613570

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.